Biocytogen Enters into Antibody Agreement with Merck KGaA, Darmstadt, Germany
/PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck...
Stay updated with breaking news from Jenna Frame. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck...
Biocytogen Enters into Antibody Agreement with Merck KGaA, Darmstadt, Germany - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck...
25 febbraio 2021 16:47 Fonte: Adnkronos #salute-e-benessere BOSTON, Feb. 25, 2021 /PRNewswire/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogen's antibody discovery service platform in the greater Boston area for collaborations across the globe. Founded on its successful gene editing platform, Biocytogen recently developed humanized immunoglobulin mice that carry the full variable region repertoire (Re...